Medicinal Chemistry ( IF 1.9 ) Pub Date : 2021-05-31 , DOI: 10.2174/157340641705210524122637 Blanka Klimova 1 , Kamil Kuca 2 , Michal Novotny 2 , Petra Maresova 3
In the following article, the author reported an error in the abstract’s result section [1].
The results section of the abstract has been changed as follows:
Results: The main benefits (e.g., specialized centres for the treatment of CF exist or a new breakthrough in the gene therapy of CF has been made) and limitations (e.g., comorbidity of CF, lifelong and costly treatment, or adverse impact on patient’s and caregiver’s quality of life) in the treatment of CF are highlighted.
The original results section of the abstract was published as:
Results: The main benefits (e.g., specialized centres for the treatment of CF exist or a new breakthrough in the gene therapy of CF has been made) and limitations (e.g., comorbidity of CF, lifelong and costly treatment, or adverse impact on patient’s and caregiver’s quality of life) in the treatment of narcolepsy are highlighted.
The original article can be found online at 10.2174/1573406412666160608113235
中文翻译:
更正:重新审视囊性纤维化 - 一项回顾性研究
在下面的文章中,作者在摘要的结果部分 [1] 中报告了一个错误。
摘要的结果部分已更改如下:
结果:主要益处(例如,存在治疗 CF 的专业中心或在 CF 基因治疗方面取得新突破)和局限性(例如,CF 的合并症、终生且昂贵的治疗,或对患者和照料者的生活质量)在 CF 治疗中得到强调。
摘要的原始结果部分发表为:
结果:主要益处(例如,存在治疗 CF 的专业中心或在 CF 基因治疗方面取得新突破)和局限性(例如,CF 的合并症、终生且昂贵的治疗,或对患者和照顾者的生活质量)在发作性睡病的治疗中得到强调。
原文可在10.2174/1573406412666160608113235在线找到